Solriamfetol
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB14754 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 58 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | attention deficit-hyperactivity disorder | KG + DL |
| 2 | faciodigitogenital syndrome | KG + DL |
| 3 | insomnia (disease) | KG + DL |
| 4 | attention deficit hyperactivity disorder, inattentive type | KG + DL |
| 5 | chondromyxoid fibroma | KG + DL |
| 6 | specific developmental disorder | KG + DL |
| 7 | variably protease-sensitive prionopathy | KG + DL |
| 8 | multiple system atrophy | KG + DL |
| 9 | postural orthostatic tachycardia syndrome | KG + DL |
| 10 | disorder of peroxisomal alpha-, beta- and omega-oxidation | KG + DL |
| 11 | Creutzfeldt-Jakob disease | KG + DL |
| 12 | ACBD5 deficiency | KG + DL |
| 13 | narcolepsy, susceptibility to | KG + DL |
| 14 | megaconial type congenital muscular dystrophy | KG + DL |
| 15 | hypersomnia (disease) | KG + DL |
| 16 | circadian rhythm sleep disorder | KG + DL |
| 17 | narcolepsy without cataplexy | KG + DL |
| 18 | sinoatrial node disease | KG + DL |
| 19 | sinoatrial block | KG + DL |
| 20 | sleep disorder, initiating and maintaining sleep | KG + DL |
| 21 | autosomal dominant cerebellar ataxia | KG + DL |
| 22 | Wernicke-Korsakoff syndrome | KG + DL |
| 23 | cerebellar ataxia | KG + DL |
| 24 | spinocerebellar degeneration with slow eye movements | KG + DL |
| 25 | cerebrospinal fluid rhinorrhea | KG + DL |
| 26 | sensory ataxia | KG + DL |
| 27 | decompression sickness | KG + DL |
| 28 | spinal cord neoplasm | KG + DL |
| 29 | optic disk drusen | KG + DL |
| 30 | low tension glaucoma | KG + DL |
| 31 | cranial neuralgia | KG + DL |
| 32 | trigeminal nerve disease | KG + DL |
| 33 | borna disease | KG + DL |
| 34 | vascular myelopathy | KG + DL |
| 35 | occlusion of tributary of retinal vein | KG + DL |
| 36 | transient retinal arterial occlusion | KG + DL |
| 37 | partial arterial retinal occlusion | KG + DL |
| 38 | channelopathy-associated congenital insensitivity to pain, autosomal recessive | KG + DL |
| 39 | acute intermittent porphyria | KG + DL |
| 40 | myoclonus, familial | KG + DL |
| 41 | papilledema | KG + DL |
| 42 | mesial temporal lobe epilepsy with hippocampal sclerosis | KG + DL |
| 43 | peripheral motor neuropathy-dysautonomia syndrome | KG + DL |
| 44 | benign paroxysmal torticollis of infancy | KG + DL |
| 45 | restless legs syndrome | KG + DL |
| 46 | dysthymic disorder | KG + DL |
| 47 | acute encephalopathy with biphasic seizures and late reduced diffusion | KG + DL |
| 48 | early myoclonic encephalopathy | KG + DL |
| 49 | trichotillomania | KG + DL |
| 50 | mitochondrial membrane transport disorder | KG + DL |
(Showing top 50 of 58 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.